In Bold Move, FDA Approves Cancer Drug For Any Advanced Tumor With Genetic Changes

as seen in Forbes

The FDA’s accelerated approval of this drug might surprise traditional oncologists. It suggests the agency may be ditching an archaic system for classifying cancers based on body parts—like breast or liver or colon cancer—and instead will focus..